What does Ardelyx, Inc. do?
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate…
What is Ardelyx, Inc.'s P/E and P/B ratio?
Ardelyx, Inc. has a P/E ratio of -13.9 and a P/B ratio of 5.54.
What is Ardelyx, Inc.'s debt-to-equity ratio?
Ardelyx, Inc. has a debt-to-equity ratio of 1.90.
How much does Ardelyx, Inc. owe compared with what it owns?
Ardelyx, Inc. owes $0.74 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is Ardelyx, Inc.'s Positivity rank?
Ardelyx, Inc. is ranked #5,390 of 6,774 companies globally and #2,922 of 4,000 in United States on PositoAI, with a Positivity Score of 17,535.
Does Ardelyx, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Ardelyx, Inc..
Where can I read the latest news about Ardelyx, Inc.?
Recent headlines about Ardelyx, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Ardelyx, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Ardelyx, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.